Hyperglycaemia in pregnancy by Sobngwi, Eugene
PUBLICATION





































Translating developmental origins 
of health and disease science to 
improve future health in Africa
At STIAS, the ‘Health in Transition’ theme includes a programme to address the epidemic 
rise in the incidence of non-communicable diseases (NCDs) such as Type 2 diabetes, 
hypertension, obesity, coronary heart disease and stroke in Africa. The aim is to advance 
awareness, research capacity and knowledge translation of science related to the 
Developmental Origins of Health and Disease (DOHaD) as a means of preventing NCDs in 
future generations.
Application of DOHaD science is a promising avenue for prevention, as this field is 
identifying how health and nutrition from conception through the first 1 000 days of life can 
dramatically impact a developing individual’s future life course, and specifically predicate 
whether or not they are programmed in infancy to develop NCDs in later life. 
Prevention of NCDs is an essential strategy as, if unchecked, the burden of caring for a 
growing and ageing population with these diseases threatens to consume entire health 
budgets, as well as negatively impact the quality of life of millions. 
Africa in particular needs specific, focussed endeavours to realise the maximal preventive 
potential of DOHaD science, and a means of generating governmental and public awareness 
about the links between health in infancy and disease in adult life. 
This volume summarises the expertise and experience of a leading group of international 
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According to the International Diabetes Federation, the burden of diabetes 
is progressively rising worldwide with an expected doubling of prevalence in 
most low- and middle-income settings within twenty-five years. The projected 
surge in diabetes prevalence to epidemic proportions reflects the ongoing 
so-called epidemiological transition experienced across most of the fastest-
growing economies. The concept of epidemiological transition is characterised 
by the reduction in infectious disease burden and a quasi-parallel rise in chronic 
non-communicable disease burden as the result of better health care, reduced 
fertility, lifestyle changes, increased life expectancy and changing age structure 
of populations. 
1 Stellenbosch Institute for Advanced Study, Wallenberg Research Centre at Stellenbosch 
University, Stellenbosch, South Africa; Laboratory of Molecular Medicine and 
Metabolism, University of Yaoundé, Cameroon.
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The specificity of epidemiological transition in most African nations is its 
accelerated character compared to most Western countries where the transition 
took place over two to three centuries. As a result, chronic non-communicable 
diseases frequently occur at a lower age than previously reported, including in 
women of childbearing age.
This chapter reviews key knowledge about the pathophysiology and consequences 
of hyperglycaemia in pregnancy, and their implication for screening, diagnosis and 
management strategy in high risk but resource-limited populations, with special 
emphasis on Africa. 
Introduction
Hyperglycaemia in pregnancy has adverse consequences for the mother, the 
outcome of pregnancy, and her offspring, in turn creating challenges for care 
providers and the healthcare system. Underdiagnosis, and the resulting absence and 
sub-optimal management further increase the related burden. In developmental 
origins of health and disease (DOHaD) perspective, hyperglycaemia in pregnancy 
is an issue of major importance because it is frequent, often asymptomatic and 
undiagnosed, has a proven impact on the fetus and the infant after birth, and 
its effects then extend into adult age. Changes in the internationally accepted 
diagnostic criteria and strategies for management have raised concern and 
recognised the need for clarification. Despite the scarcity of population-based data 
from the most affected parts of the world, there is growing evidence from Africa to 
suggest a rise in early-onset diabetes and hyperglycaemia in pregnancy. 
Despite progress in maternal and child health globally, adverse pregnancy outcomes 
remain unacceptably high in most sub-Saharan African countries, where they are 
mainly due to preventable causes.2 One of those preventable causes, gestational 
diabetes, disproportionately affects women of African ethnicity.3 Diabetes mellitus 
2 Lawn, J.E., Blencowe, H., Pattinson, R., Cousen, S., Kumar, R., Ibiebele, I., Gardosi, J., 
Day, L.T., Stanton, C. & Lancet’s Stillbirths Series Steering Committee. 2011. Stillbirths: 
Where? When? Why? How to make the data count? The Lancet, 377(9775):1448‑1463. 
[https://doi.org/10.1016/S0140‑6736(10)62187‑3]; Pattinson, R., Kerber, K., 
Buchmann, E., Friberg, I.K., Belizan, M., Lansky, S., Weissman, E., Mathai, M., 
Rudan, I., Walker, N., Lawn, J.E. & Lancet’s Stillbirths Series Steering Committee. 
2011. Stillbirths: how can health systems deliver for mothers and babies? The Lancet, 
377(9777):1610‑1623. [https://doi.org/10.1016/S0140‑6736(10)62306‑9].
3 Makgoba, M., Savvidou, M.D. & Steer, P.J. 2012. An analysis of the interrelationship 
between maternal age, body mass index and racial origin in the development of 
gestational diabetes mellitus. BJOG: An International Journal of Obstetrics & Gynaecology, 
119(3):276‑282. [https://doi.org/10.1111/j.1471‑0528.2011.03156.x].
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has been associated with up to eight per cent of stillbirths in developed countries 
against less than two per cent in other parts of the world.4 However, the latter 
figures are likely underestimated, as the true magnitude of gestational diabetes 
remains unknown in most low- to-middle income countries, including those in 
Africa.5 In the absence of effective and universal screening programmes, current 
figures suggest that close to 90 per cent of cases of gestational diabetes occur in 
low- to-middle income countries including Africa while less than 10 per cent of 
African woman undergo screening for diabetes during pregnancy.6
Detecting and treating gestational diabetes provides benefits in terms of reducing 
fetal morbidity and mortality, as well as the future maternal risk of developing type 2 
diabetes mellitus.7 However, optimal strategies for gestational diabetes diagnosis 
remain elusive.8 Different diagnostic criteria have been proposed by different 
professional bodies and organisations. Recently the International Association of 
Diabetes and Pregnancy Study Group suggested new diagnostic criteria, informed 
mainly by the Hyperglycaemia and Adverse Pregnancy Outcome study. However, 
4 Lawn et al., 2011; Cousens, S., Blencowe, H., Stanton, C., Chou, D., Ahmed, S., 
Steinhardt, L., Creanga, A.A., Tunçalp, O., Balsara, Z.P., Gupta, S., Say, L. & Lawn, J.E. 
2011. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends 
since 1995: a systematic analysis. The Lancet, 377(9774):1319‑1330. [https://doi.
org/10.1016/S0140‑6736(10)62310‑0].
5 Jiwani, A., Marseille, E., Lohse, N., Damm, P., Hod, M. & Kahn, J.G. 2012. Gestational 
diabetes mellitus: results from a survey of country prevalence and practices. Journal of 
Maternal-Fetal and Neonatal Medicine, 25(6):600‑610. [https://doi.org/10.3109/1476705
8.2011.587921].
6 International Diabetes Federation (IDF). 2015. IDF Diabetes Atlas 7th 
Edition (2015). [https://www.idf.org/component/attachments/attachments.
html?id=1093&task=download] (Accessed 24 August 2016); Mwanri, A.W., Kinabo, J., 
Ramaiya, K. & Feskens, E.J. 2015. Gestational diabetes mellitus in sub‑Saharan Africa: 
systematic review and metaregression on prevalence and risk factors. Tropical Medicine & 
International Health, 20(8):983‑1002. [https://doi.org/10.1111/tmi.12521].
7 Lohse, N., Marseille, E. & Kahn, J.G. 2011. Development of a model to assess the 
cost‑effectiveness of gestational diabetes mellitus screening and lifestyle change for the 
prevention of type 2 diabetes mellitus. International Journal of Gynecology & Obstetrics, 
115(Supplement 1):20‑25. [https://doi.org/10.1016/S0020‑7292(11)60007‑6]; 
Ohno, M.S., Sparks, T.N., Cheng, Y.W. & Caughey, A.B. 2011. Treating mild gestational 
diabetes mellitus: a cost‑effectiveness analysis. American Journal of Obstetrics and 
Gynecology, 205(3):282.e1‑7. [https://doi.org/10.1016/j.ajog.2011.06.051].
8 Simmons, D., McElduff, A., McIntyre H.D. & Elrishi, M. 2010. Gestational Diabetes 
Mellitus: NICE for the U.S.? A Comparison of the American Diabetes Association and 
the American College of Obstetricians and Gynecologists Guidelines With the U.K. 
National Institute for Health and Clinical Excellence Guidelines: Response to Holt et al. 
Diabetes Care, 33:34‑37. [https://doi.org/10.2337/dc09‑2335].
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even these new criteria are somewhat arbitrary, as this study identified continuous 
associations between maternal glucose levels and several perinatal outcomes, 
extending the threshold for a gestational diabetes diagnosis.9
Because of their high risk of diabetes, women of African ethnicity are offered 
universal screening for gestational diabetes in most developed countries. Such 
universal screening is not often available in developing countries because of poor 
financial and health care resources, and competing health priorities. Adequate 
approaches should account for the overall population risk and coping capacity of 
the health systems. Awareness of risk factors such as a family history of diabetes is 
as low as 30 per cent in most sub-Saharan Africa settings.10 Moreover, diagnosing 
gestational diabetes requires the resource- and labour-intensive oral glucose 
tolerance test, seldom performed in African settings due to many constraints.11 
Consequently, gestational diabetes is either not screened for at all or is screened 
using inaccurate tests such as urine glucose. 
Drivers of the risk of hyperglycaemia in pregnancy
Classification and considerations
Hyperglycaemia and hypertension are among the most common medical 
conditions encountered during pregnancy; estimates are that one in six live births 
occur in a context of maternal hyperglycaemia in pregnancy. However, because 
of greater prevalence of maternal and fetal complications resulting from diabetes 
mellitus antedating pregnancy, the International Federation of Obstetrics and 
Gynaecology has recommended that hyperglycaemia first detected at any time 
during pregnancy should be classified as either diabetes mellitus in pregnancy or 
gestational diabetes mellitus to account for this important fact and etiopathogenesis. 
Maternal hyperglycaemia in pregnancy may thus be either due to pre-existing 
diabetes (type 1 or type 2) antedating pregnancy (estimated to be approximately 
16 per cent of cases), or diabetes diagnosed for the first time in pregnancy where 
9 Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative 
Research Group, Metzger, B.E., Lowe, L.P., Dyer, A.R., Trimble, E.R., Chaovarindr, 
U., Coustan, D.R., Hadden, D.R., McCance, D.R., Hod, M., McIntyre, H.D., Oats, 
J.J., Persson, B., Rogers, M.S., Sacks, D.A. 2008. Hyperglycemia and adverse pregnancy 
outcomes. The New England Journal of Medicine, 358(19):1991‑2002. [https://doi.
org/10.1056/NEJMoa0707943].
10 Mbanya, J.C., Motala, A.A., Sobngwi, E., Assah, F.K. & Enoru, S.T. 2010. Diabetes 
in sub‑Saharan Africa. The Lancet, 375:2254‑2266. [https://doi.org/10.1016/S0140‑
6736(10)60550‑8].
11 Jiwani et al., 2012.
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studies meet the World Health Organization (WHO) criterion for diabetes mellitus 
in the non-pregnant state or due to gestational diabetes. The most commonly 
accepted definition of gestational diabetes is ‘any degree of glucose intolerance 
with onset or first recognition during pregnancy’.12 Compared to gestational 
diabetes, diabetes mellitus antedating pregnancy is more likely to be detected early 
(e.g. during the first trimester), provided appropriate testing is undertaken. While 
gestational diabetes is generally evident later in the course of pregnancy (often 
24-28 weeks), it is diagnosed at any time when glucose levels meet the WHO 
criterion for the diagnosis of gestational diabetes (see Figure 9.1).
Figure 9.1  Schematic for the distinction between diabetes in pregnancy  
  and gestational diabetes mellitus.
The role of classic factors
Due to shared risk factors, the occurrence of gestational diabetes parallels the 
prevalence of impaired glucose tolerance, obesity and type 2 diabetes in a given 
population. Worldwide, overweight and obesity are increasing in women of 
reproductive age, and the age of onset of diabetes is declining while the age of 
childbearing is increasing. Thus, in addition to family/genetic predisposition, 
increasing age combined with sedentary behaviour coupled with an unhealthy diet 
12 American Diabetes Association. 2003. Gestational Diabetes Mellitus. Diabetes Care, 
26(Supplement 1): 103‑105. [https://doi.org/10.2337/diacare.26.2007.S103].
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and the resulting obesity, indicating more women entering pregnancy having risk 
factors that make them vulnerable to hyperglycaemia during pregnancy. 
Other factors
Previous gestational diabetes is associated with a seven-fold lifetime risk of 
developing persistent type 2 diabetes. In the context of low diabetes awareness, 
unrecognised diabetes is, therefore, a potential additional factor. The other risk 
factors for gestational diabetes include ethnicity, high parity, excessive weight 
gain in the index pregnancy, polycystic ovarian syndrome, a history of poor 
pregnancy outcome (abortion, fetal loss), macrosomia in previous and/or index 
pregnancy, gestational diabetes in a previous pregnancy, preeclampsia and 
multi-fetal pregnancy.13
The second half of pregnancy is a diabetogenic state
Despite extensive investigation of risk factors, it is reported that none is found 
in about half of women diagnosed with gestational diabetes. The second half of 
pregnancy per se is considered a diabetogenic state for physiological reasons. During 
pregnancy, the fetus must be nourished continuously despite the intermittent 
feeding of the mother, achieved through the fetal-placental-maternal unit being 
under the control of placental hormonal secretions that promote maternal 
insulin resistance. Insulin resistance increases throughout pregnancy and is well 
established by the 24th week. Maternal hyperglycaemia occurs in circumstances of 
the failure to increase insulin secretion or additional insulin resistance in otherwise 
predisposed women. 
Consequences of hyperglycaemia in pregnancy
Overview
Hyperglycaemia in pregnancy is associated with increased risk of adverse events 
affecting the mother, compromising the fetus, complicating the delivery process, 
and increasing morbidity in newborn infants. We now know it has long-term 
consequences in the offspring (see Table 9.1).
In the case of diabetes in pregnancy, as hyperglycaemia may have been present at 
conception and embryogenesis increases the vulnerability and risk of complications. 
Hyperglycaemia during the critical period of organogenesis may lead to a high risk 
of spontaneous abortions and congenital anomalies. Microvascular complications 
13 Metzger et al., 2008.
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of diabetes such as retinopathy or nephropathy, are also more likely in the mother 
and tend to exacerbate during pregnancy.
Gestational diabetes more commonly implies relatively milder hyperglycaemia 
compared to diabetes in pregnancy but is nonetheless associated with poor 
pregnancy outcome in the absence of appropriate management, and future risk of 
diabetes and cardiovascular disease. 
Gestational diabetes is associated with a higher incidence of maternal morbidity, 
including caesarean deliveries, shoulder dystocia, birth trauma, hypertensive 
disorders of pregnancy (including preeclampsia) and subsequent development 
of type 2 diabetes. Perinatal and neonatal morbidities are also increased; the 
latter include macrosomia, birth injury, hypoglycaemia, polycythaemia and 
hyperbilirubinemia. Long-term sequelae in offspring with in utero exposure 
to maternal hyperglycaemia include higher risks of obesity, impaired glucose 
metabolism and diabetes later in life. 
Relevance to DOHaD
Growth and development of the human conceptus occur within the metabolic 
milieu provided by the mother and the fetus and are dependent on the transfer of 
nutrients from the maternal circulation via the placenta. Early studies demonstrated 
that newborn infants of diabetic mothers suffered from hypoglycaemia.14 It 
was hypothesised that this was due to hyperinsulinism as a consequence of 
the increased transplacental transfer of sugar, and later research confirmed the 
presence of hyperplasia of the insulin-producing β cells in infants of diabetic 
mothers. Ultimately, hyperplasia could have consequences in later life; in animal 
experiments, Aerts and Van Assche showed that modifications in the endocrine 
pancreas during intrauterine life cause persistent changes in later adult life (second 
generation), which though not perceptible in basal conditions, become apparent 
in situations stressing the β cell activity, such as pregnancy.15 During pregnancy in 
the second-generation rats, increased non-fasting blood glucose and no adaptation 
of the β cells is seen. This inadequate adaptation to pregnancy causes changes 
in the fetal endocrine pancreas of third-generation fetuses, thereby suggesting 
a transgenerational transmission of risk. It is now evident that an abnormal 
intrauterine environment has consequences in later life mediated through 
14 Jacobsen, B.B., Nielsen, F., Pedersen, V.F. & Kildeberg, P. 1988. Residual β cell function 
in transient neonatal diabetes mellitus (TNDM). Pediatric Research, 23:115.  
[https://doi.org/10.1203/00006450‑198801000‑00083].
15 Aerts, L. & Van Assche, F.A. 2006. Animal evidence for the transgenerational 
development of diabetes mellitus. The International Journal of Biochemistry & Cell Biology, 
38(5‑6):894‑903. [https://doi.org/10.1016/j.biocel.2005.07.006].
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epigenetic changes and is known as developmental programming. So, it can be 
concluded that fetal development in an abnormal intrauterine milieu can induce 
alterations in fetal metabolism, with lasting consequences for the glucose tolerance 
of the offspring in adult life.16 The most marked effects being the development of 
gestational diabetes and with it the transmitting of a diabetogenic tendency to the 
next generation.
Table 9.1  Adverse events associated with hyperglycaemia in pregnancy. 
Maternal and Fetal morbidity associated with gestational diabetes (adapted from the International 
Federation of Obstetrics and Gynaecology)
Maternal
 ■ Pre-and Early Pregnancy
– Spontaneous abortions
 ■ During Pregnancy
– Preeclampsia
– Gestational hypertension
– Excessive fetal growth (macrosomia, low gestational age)
– Hydramnios











– Failure to initiate &/or maintain breastfeeding
– Infection
 ■ Long-Term Post-Partum
– Weight retention
– Gestational diabetes in a subsequent pregnancy
– Future overt diabetes
– Future cardiovascular disease
Fetal/Neonatal
16 Fetita, L.S., Sobngwi, E., Serradas, P., Calvo, F. & Gautier, J.F. 2006. Consequences of 
fetal exposure to maternal diabetes in offspring. The Journal of Clinical Endocrinology and 
Metabolism, 91(10):3718‑3724. [https://doi.org/10.1210/jc.2006‑0624].
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Maternal and Fetal morbidity associated with gestational diabetes (adapted from the International 
Federation of Obstetrics and Gynaecology)
– Stillbirth
– Neonatal death
– Non-chromosomal congenital malformations






– Erb’s palsy (as a consequence of birth injury)
DOHaD
– Increased predictors and risk of diabetes, obesity, and hypertension in offspring at adult age
An increasing body of evidence supports the hypothesis that the abnormal 
metabolic environment of the mother with diabetes mellitus may affect specific 
developing fetal tissues, organs and control systems that will eventually lead to 
permanent long-term functional implications in adult life. The fetal tissues most 
likely to be affected are neural cells, adipocytes, muscle cells and pancreatic β 
cells. Freinkel & Metzger (1979) introduced the concept of pregnancy as a ‘tissue 
culture experiment’, in which the placenta and the fetus develop in an ‘incubating 
medium’ totally derived from maternal fuels. All these fuels traverse the placenta 
from the maternal compartment either with (e.g. glucose, lipids) or against (e.g. 
amino acids) concentration gradients and thus contribute to the fetal milieu. 
Since these constituents are regulated in part by maternal insulin, disturbances in 
its supply or actions influence the entire nutritional content to which the fetus is 
exposed; maternal hyperglycaemia leads to fetal hyperglycaemia and eventually to 
fetal hyperinsulinemia. According to Freinkel & Metzger (1979)’s hypothesis, the 
abnormal mixture of metabolites from the mother gains access to the developing 
fetus in utero, modifying the phenotypic expression in newly-formed cells, in turn 
determining permanent, short- and long-term effects in the offspring.17 Depending 
upon the timing of (embryonic-fetal) exposure to the aberrant fuel mixture, 
different events may develop. Early in the first trimester, intrauterine growth 
restriction and organ malformation, described by Freinkel & Metzger (1979) as 
17 Freinkel, N. & Metzger, B.E. 1979. Pregnancy as a tissue culture experience: the critical 
implications of maternal metabolism for fetal development. Ciba Foundation Symposium 
63: Pregnancy Metabolism, Diabetes and the Fetus, (63):3‑28.  
[https://doi.org/10.1002/9780470720462.ch2].
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‘fuel-mediated teratogenesis’ may occur.18 During the second trimester, at the time 
of brain development and differentiation, behavioural, intellectual or psychological 
damage may occur. During the third trimester, abnormal proliferation of fetal 
adipocytes and muscle cells, together with hyperplasia of pancreatic β cells 
and neuroendocrine cells may be responsible for the development of obesity, 
hypertension and type 2 diabetes later in life.
Figure 9.2  Schematic of the fetal and neonatal effects of intrauterine  
  exposure to maternal hyperglycaemia.
Implications for diagnosis
Historical perspective
After decades of uncertainty about the diagnostic criteria of hyperglycaemia in 
pregnancy, there is an emerging consensus following extensive large studies of 
outcomes around International Association of Diabetes and Pregnancy Study 
Group-derived criteria as presented by the WHO in 2013. It is recommended to 
use a two-hour 75g oral glucose tolerance test with fasting, one-hour and two-hour 
18 Freinkel & Metzger, 1979.
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criteria as shown in Table 9.1. There is, however, a lack of consensus across the 
world for the best screening strategy, whether a universal one-step, a two-step or a 
risk factor-based screening approach should be used.19
African perspective
Recent studies on the prevalence and risk factors of gestational diabetes in an 
African setting include those by Mwanri, Kinabo, Ramaiya and Feskens (2015); 
Macaulay, Dunger and Norris (2014); and OlagbujI and colleagues (Atiba, 
Olofinbiyi, Akintayo, Awoleke, Ade-Ojo and Fasubaa and the Gestational Diabetes 
Study Group-Nigeria, 2015).20 Mwanri et al. reported a PubMed-Medline 
based systematic review of studies published up to June 2014. The 22 studies 
identified were from Western (n=11), Southern (n=5), Eastern (n=4) and Central 
(n=2) Africa.21
Diagnostic criteria for gestational diabetes varied widely between these studies. 
Using a 50g glucose challenge test and WHO 1999 criteria, the prevalence of 
gestational diabetes ranged from 1.5 to three per cent and one to 13.9 per cent, 
respectively. None of the included studies used criteria from the International 
Association of Diabetes and Pregnancy Study Group 2010 or the National Institute 
19 Atun, R., Davies, J.I., Gale, E.A., Bärnighausen, T., Beran, D., Kengne, A.P., Levitt, N.S., 
Mangugu, F.W., Nyirenda, M.J., Ogle, G.D. & Ramaiya, K., Sewankambo, N.K., 
Sobngwi, E., Tesfaye, S., Yudkin, J.S., Basu, S., Bommer, C., Heesemann, E., 
Manne‑Goehler, J., Postolovska, I., Sagalova, V., Vollmer, S., Abbas, Z.G., Ammon, B., 
Angamo, M.T., Annamreddi, A., Awasthi, A., Besançon, S., Bhadriraju, S., 
Binagwaho, A., Burgess, P.I., Burton, M.J., Chai, J., Chilunga, F.P., Chipendo, P., 
Conn, A., Joel, D.R., Eagan, A.W., Gishoma, C., Ho, J., Jong, S., Kakarmath, S.S., 
Khan, Y., Kharel, R., Kyle, M.A., Lee, S.C., Lichtman, A., Malm, C.P., Mbaye, M.N., 
Muhimpundu, M.A., Mwagomba, B.M., Mwangi, K.J., Nair, M., Niyonsenga, S.P., 
Njuguna, B., Okafor, O.L.O., Okunade, O., Park, P.H., Pastakia, S.D., Pekny, C., 
Reja, A., Rotimi, C.N., Rwunganira, S., Sando, D., Sarriera, G., Sharma, A., Sidibe, A., 
Siraj, E.S., Syed, A.S., Van Acker, K. & Werfalli, M. 2017. Diabetes in sub‑Saharan 
Africa: from clinical care to health policy. The Lancet Diabetes & Endocrinology, 
5(8):622‑667. [https://doi.org/10.1016/S2213‑8587(17)30181‑X].
20 Macaulay, S., Dunger, D.B. & Norris, S.A. 2014. Gestational diabetes mellitus in Africa:  
a systematic review. PLoS One, 9:e97871. [https://doi.org/10.1371/journal.one.0097871]; 
Olagbuji, B.N., Atiba, A.S., Olofinbiyi, B.A., Akintayo, A.A., Awoleke, J.O., Ade‑Ojo, I.P. 
& Fasubaa, O.B. & Gestational Diabetes Study Group‑Nigeria. 2015. Prevalence of and 
risk factors for gestational diabetes using 1999, 2013 WHO and IADPSG criteria upon 
implementation of a universal one‑step screening and diagnostic strategy in a sub‑Saharan 
African population. European Journal of Obstetrics & Gynecology and Reproductive Biology, 
189:27‑32. [https://doi.org/10.1016/j.ejogrb.2015.02.030].
21 Mwanri et al., 2015.
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for Health and Clinical Excellence 2015. Overweight or obesity, family history 
of diabetes, macrosomia or age older than 30 years were the main risk factors of 
gestational diabetes. Macaulay et al. reported the prevalence of gestational diabetes 
(estimate: 9.3 per cent) using criteria of the WHO or the American Diabetes 
Association 2012, while Olagbuji et al. used criteria of the WHO 1999, the 
WHO 2013, the modified International Association of Diabetes and Pregnancy 
Study Group and the International Association of Diabetes and Pregnancy Study 
Group, and reported prevalence rates of 3.8 per cent, 8.1 per cent, 7.5 per cent 
and 8.6 per cent.22 Glycosuria was the only correlate of gestational diabetes based 
on criteria of the WHO 2013 and the International Association of Diabetes and 
Pregnancy Study Group.
For the first time in an African population, we have explored the diagnostic utility 
of fasting plasma glucose or random blood glucose alone and the added value of 
50g glucose challenge test and the performance of the guidelines for gestational 
diabetes screening of the WHO 1999, the International Association of Diabetes 
and Pregnancy Study Group 2010 and the National Institute for Health and 
Clinical Excellence 2015. 
We conducted a cross-sectional study among pregnant women attending antenatal 
clinics in two major cities in Cameroon. We enrolled consenting pregnant women 
who attended antenatal care at the participating health facilities, on a consecutive 
basis until reaching a target sample of 1 000. Pregnant women at 24-28 weeks of 
gestation were eligible. We excluded women with known diabetes based on medical 
records. Overall, each consenting participant underwent a risk factor assessment, a 
random blood glucose test, a fasting plasma glucose test, a one-hour 50g glucose 
challenge test and a two-hour 75g oral glucose tolerance test. 
Risk factor assessment
A structured questionnaire was used to record risk factors for gestational diabetes, 
including age, occupation, education level, parity, history of a previous stillbirth, 
history of macrosomia (birth weight ≥ 4 000g), physical activity levels, dietary 
habits, and characteristics of the ongoing pregnancy. Blood pressure was the 
average from three consecutive measurements in a sitting position after a ten-
minute rest using an Omron M4® recorder. Height and weight were measured in 
light indoor clothing and without shoes. The body mass index was calculated in 
kg/m2. Overweight was defined as having a body mass index of ≥ 25kg/m² and 
obesity as ≥ 30kg/m².
22 Macaulay, Dunger & Norris, 2014; Olagbuji et al., 2015.
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Testing for gestational diabetes
The women underwent biochemical testing for gestational diabetes on two 
different occasions. At the first visit, a random plasma glucose test and a one-hour 
post load 50g glucose challenge test were conducted. At the second visit within 
one week of the first one, participants underwent testing (after an eight to 12-
hour overnight fast) including fasting plasma glucose test, and a 75g oral glucose 
tolerance test with an assessment of blood glucose at 30, and 120 minutes after a 
glucose load.
Diagnostic criteria for gestational diabetes
Gestational diabetes was defined by applying three sets of criteria:
  The WHO’s definition (1999) as either fasting plasma glucose ≥ 7mmol/L 
or two-hour post a 75g oral glucose tolerance test, plasma glucose (two-hour 
PG) ≥ 7.8mmol/L;23
  An approximation of the International Association of Diabetes and Pregnancy 
Study Group-criteria as either fasting plasma glucose ≥ 5.1 mmol/L or two-
hour PG ≥ 8.5mmol/L;24 and
  The National Institute for Health and Clinical Excellence 2015-criteria as 
fasting plasma glucose ≥ 5.6mmol/L and two-hour PG ≥ 7.8mmol/L.25
Implications of the evidence
The prevalence of gestational diabetes in Cameroon varies substantially across 
diagnostic criteria, from 5.9 per cent by the WHO criteria to 17.7 per cent by the 
International Association of Diabetes and Pregnancy Study Group-criteria, and 11 
per cent by the National Institute for Health and Clinical Excellence-criteria. The 
presence of gestational diabetes appears to be determined by previous obstetrical 
23 World Health Organization (WHO). 1999. Definition, diagnosis and classification of 
diabetes mellitus and its complications: Report of a WHO consultation. Part 1, Diagnosis 
and classification of diabetes mellitus. [https://apps.who.int/iris/handle/10665/66040] 
(Accessed 10 September 2019).
24 Metzger, B.E., Gabbe, S.G., Persson, Lowe, L.P., Dyer, A.R., Oats, J.M. & Buchanan, T.A. 
2010. International association of diabetes and pregnancy study groups recommendations 
on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care, 
33(3):676‑682. [https://doi.org/10.2337/dc09‑1848].
25 National Institute for Health and Care Excellence. 2015. Diabetes in pregnancy: 
management from preconception to the postnatal period. NICE guideline [NG3].  
[nice.org.uk/guidance/ng3] (Accessed 10 September 2019).
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history and dietary habits. Irrespective of the diagnostic criteria and tests thresholds 
used, a considerable proportion of women was likely to have severe glucose 
intolerance and thus was at risk for adverse perinatal outcomes. A conceptually 
simple diagnostic algorithm with optimal screening yield can be derived based 
on the performance of various tests in this population and is potentially useful for 
routine clinical practice in resource-limited settings. 
The prevalence of gestational diabetes depends on the chosen screening strategy 
with the highest prevalence obtained using guidelines of the International 
Association of Diabetes and Pregnancy Study Group. Irrespective of the diagnostic 
criteria and test thresholds used, a considerable proportion of women have severe 
glucose intolerance and are thus at risk for adverse perinatal outcomes. Physical 
activity, history of stillbirth and alcohol consumption, age, family history of 
diabetes and macrosomia are significant determinants of gestational diabetes in 
African populations. Unlike random blood glucose, fasting plasma glucose could be 
used in a simple screening algorithm to define the segment of pregnant women to 
be further screened via a 75g oral glucose tolerance test. Where feasible, however, 
a single step testing strategy using a 75g oral glucose tolerance test is optimal for 
gestational diabetes screening.
Based on the performance of the screening tests used in our study we propose 
a simple screening algorithm to optimally identify women with gestational 
diabetes in sub-Saharan Africa where limited resources are a major deterrent to 
the implementation of a large-scale and sustainable programme for prevention 
and management of gestational diabetes-associated complications. The screening 
algorithm is practical for resource-limited settings and uses fasting glucose 
measurements, as shown in Figure 9.2. Such a screening strategy, allowing testing 
of pregnant women first in a fasting state, will facilitate an opportunistic approach 
to screening and has the potential to maximise the yield of screening in an 
environment where regular clinic attendance can be an issue. 
Comparison with other studies and explanation of our results
A recent study from Nigeria using the WHO criteria to diagnose gestational 
diabetes reported a prevalence of 8.3 per cent; whereas a previous South-African 
study found a much lower prevalence (1.5 per cent) with similar criteria in a 
rural setting.26
26 Atun et al., 2017; Mamabolo, R.L., Alberts, M., Levitt, N.S., Delemarre‑van de 
Waal, H.A. & Steyn, N.P. 2007. Prevalence of gestational diabetes mellitus and the 
effect of weight on measures of insulin secretion and insulin resistance in third‑trimester 
pregnant rural women residing in the Central Region of Limpopo Province, South Africa. 
Diabetic Medicine, 24(3):233‑239. [https://doi.org/10.1111/j.1464‑5491.2006.02073.x].
AJ Macnab, A Daar & C Pauw (eds). Health in Transition. Stellenbosch: African Sun Media
https://doi.org/10.18820/9781928357759/09 Copyright 2020 African Sun Media and STIAS
Hyperglycaemia in pregnancy  |      157
Such differences in gestational diabetes prevalence with previous studies may relate 
to the fact that these studies have used different screening strategies and diagnostic 
criteria than those of the screening approach in this study. Elevated rates of 
gestational diabetes in Cameroonian women may be related to the growing obesity 
in women in sub-Saharan Africa.27 In our study, only previous stillbirth and alcohol 
consumption were associated with the presence of gestational diabetes. There 
are several possible explanations for the lack of association between traditionally 
known risk factors and gestational diabetes, which include our relatively small 
sample size with a low prevalence of some of these risk factors in our sample, or the 
low awareness of these risk factors in our population. The paradoxical association 
of increased physical activity from walking with a high prevalence of gestational 
diabetes may simply be related to chance or the subjective nature of physical 
activity assessment. 
Figure 9.3  Proposed screening algorithm for gestational diabetes in  
  resource-limited settings.
Our estimates of the performance of various screening tests differ from those 
reported in previous studies.28 The observed difference is at least partially related 
27 Mwanri et al., 2015; Macaulay, Dunger & Norris, 2014.
28 Senanayake, H., Seneviratne, S., Ariyaratne, H. & Wijeratne, S. 2006. Screening 
for gestational diabetes mellitus in southern Asian women. Journal of Obstetrics 
and Gynaecology Research, 32(3):286‑291. [https://doi.org/10.1111/j.1447‑
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to population structure with potential differential gestational diabetes baseline risk, 
sample size and tests used, as well as cut-offs. Indeed, many previous studies did 
not include random blood glucose in their assessment, although it is a fast, simple, 
and relatively inexpensive test. However, its accuracy has been less frequently 
studied than that of other screening tests, with indications that its performance 
as a screening test for gestational diabetes may be limited. Nasrat, Johnstone and 
Hasan (1988) found a sensitivity of 16 per cent and a specificity of 96 per cent 
using a threshold value of 7mmol/L or 6.4mmol/L if evaluated against two-
hour postprandial.29 Consistent with our findings, Jowett, Samanta and Burden 
(2017) concluded that random glucose measurement might not be sufficiently 
sensitive for screening on gestational diabetes as a stand-alone test.30 Despite these 
limitations, from a public health perspective, including fasting plasma glucose as 
an initial test in a stepwise screening for gestational diabetes using a combination 
of various tests, appear as a promising practical approach for detecting gestational 
diabetes in under-resourced settings (where universal screening is not always 
possible). Opportunistic screening with random blood glucose would lead to more 
gestational diabetes cases diagnosed.
Conclusion
Rapid demographic, sociocultural, and economic transitions are driving increases 
in the risk and prevalence of diabetes and other non-communicable diseases in 
sub-Saharan Africa. The impacts of these transitions and their health and economic 
consequences are evident. In 1990, the leading causes of death in sub-Saharan 
Africa were HIV/Aids, lower respiratory infections, diarrhoeal diseases, malaria, 
and vaccine-preventable diseases in children. In more recent years, cardiovascular 
diseases and their risk factors are replacing infectious diseases as the leading 
causes of death in this region, and rates of increased cardiovascular risk factors are 
0756.2006.00400.x]; Agarwal, M.M., Dhatt, G.S. & Punnose, J. 2006. Gestational 
diabetes: utility of fasting plasma glucose as a screening test depends on the diagnostic 
criteria. Diabetic Medicine, 23(12):1319‑1326. [https://doi.org/10.1111/j.1464‑
5491.2006.01987.x]; Agarwal, M.M., Dhatt, G.S. & Shah, S.M. 2010. Gestational 
diabetes mellitus: simplifying the international association of diabetes and pregnancy 
diagnostic algorithm using fasting plasma glucose. Diabetes Care, 33(9):2018‑2020. 
[https://doi.org/10.2337/dc10‑0572].
29 Nasrat, A.A., Johnstone, F.D. & Hasan, S.A. 1988. Is random plasma glucose an efficient 
screening test for abnormal glucose tolerance in pregnancy? British Journal of Obstetrics 
and Gynaecology, 95(9):855‑860. [https://doi.org/10.1111/j.1471‑0528.1988.tb06569.x].
30 Jowett, N.I., Samanta, A.K. & Burden, A.C. 2017. Screening for diabetes in pregnancy: is 
a random blood glucose enough? Diabetic Medicine, 4(2):160‑3.  
[https://doi.org/10.1111/j.1464‑5491.1987.tb00854.x].
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predicted to be higher in sub-Saharan Africa than in other parts of the world. Thus, 
sub-Saharan Africa, containing a high proportion of the world’s least developed 
countries, will face the multifaceted challenge of dealing with a high burden of 
infectious diseases and diseases of poverty, while also addressing the increasing 
burden of cardiovascular disease and its risk factors. At present, many of the health 
systems in sub-Saharan Africa struggle to cope with infectious diseases. Meeting 
the goals of the United Nations high-level meeting on non-communicable diseases 
(to reduce premature mortality from non-communicable diseases by 25 per cent 
by 2025) and the Sustainable Development Goals (to reduce premature mortality 
from non-communicable diseases by a third by 2030) requires a coordinated 
approach within countries, starting with a firm consideration of disease burden, 
needs, and priorities.31
31 Atun et al., 2017.
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